|
Volumn 35, Issue 2, 2017, Pages 108-112
|
Fresh from the biotech pipeline-2016
a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTISENSE OLIGONUCLEOTIDE;
BIOLOGICAL PRODUCT;
NEW DRUG;
BIOSIMILAR AGENT;
RNA;
ARTICLE;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HUMAN;
ONCOLOGY;
PATIENT ADVOCACY;
PHARMACEUTICS;
PRIORITY JOURNAL;
REGISTRATION;
UNITED STATES;
ANTI-INFECTIVE AGENTS;
BIOSIMILAR PHARMACEUTICALS;
BIOTECHNOLOGY;
DRUG INDUSTRY;
HUMANS;
RNA;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 85012119028
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.3783 Document Type: Article |
Times cited : (15)
|
References (6)
|